Axonics R20 Post-Market Clinical Follow-up (PMCF) Study for the Indication of Fecal Incontinence

Single-Arm, multi-center, prospective, open-label registry study for commercially available rechargeable implantable neurostimulator (INS model 5101); also referred to as R20.

NCT Number	NCT07499258
Lead Sponsor	Axonics, Inc.
Conditions	Fecal Incontinence
Enrollment	55 participants
Start Date	2026-07-02
Primary Completion	2027-12 (estimated)
Study Completion	2029-12 (estimated)
Updated on ClinicalTrials.gov	2026-08-12